The new products are based on GT's LightTouch(TM) non-invasive cervical cancer detection technology, which is undergoing the U.S. Food and Drug Administration's premarket approval process.
Guided Therapeutics is a US-based developer of rapid and painless test for the early detection of disease that leads to cervical cancer, while Konica Minolta is a Japan-based developer of advanced optical components, units, and systems for various applications.
Deal Type Partnership Sub-Category Co-development Deal Status Announced: 2009-05-19
Deal Participants
Partner 1 (Company) Guided Therapeutics, Inc. (formerly SpectRx, Inc.) Partner 2 (Company) Konica Minolta Opto, Inc.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index